Aberrant hyperediting of the myeloma transcriptome by ADAR1 confers oncogenicity and is a marker of poor prognosis

10.1182/blood-2018-02-832576

Saved in:

Bibliographic Details
Main Authors:	Teoh, Phaik Ju, An, Omer, Chung, Tae-Hoon, Chooi, Jing Yuan, Toh, Sabrina HM, Fan, Shuangyi, Wang, Wilson, Koh, Bryan TH, Fullwood, Melissa J, Ooi, Melissa G, de Mel, Sanjay, Soekojo, Cinnie Y, Chen, Leilei, Ng, Siok Bian, Yang, Henry, Chng, Wee Joo
Other Authors:	CANCER SCIENCE INSTITUTE OF SINGAPORE
Format:	Article
Language:	English
Published:	AMER SOC HEMATOLOGY 2019
Subjects:	Science & Technology Life Sciences & Biomedicine Hematology MULTIPLE-MYELOMA GENE AMPLIFICATION RNA ACTIVATION ABNORMALITIES INHIBITION
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/155188
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore
Language:	English

id	sg-nus-scholar.10635-155188
record_format	dspace
spelling	sg-nus-scholar.10635-1551882024-04-18T08:29:01Z Aberrant hyperediting of the myeloma transcriptome by ADAR1 confers oncogenicity and is a marker of poor prognosis Teoh, Phaik Ju An, Omer Chung, Tae-Hoon Chooi, Jing Yuan Toh, Sabrina HM Fan, Shuangyi Wang, Wilson Koh, Bryan TH Fullwood, Melissa J Ooi, Melissa G de Mel, Sanjay Soekojo, Cinnie Y Chen, Leilei Ng, Siok Bian Yang, Henry Chng, Wee Joo CANCER SCIENCE INSTITUTE OF SINGAPORE PATHOLOGY ORTHOPAEDIC SURGERY MEDICINE Science & Technology Life Sciences & Biomedicine Hematology MULTIPLE-MYELOMA GENE AMPLIFICATION RNA ACTIVATION ABNORMALITIES INHIBITION 10.1182/blood-2018-02-832576 BLOOD 132 12 1304-1317 2019-06-06T01:36:03Z 2019-06-06T01:36:03Z 2018-09-20 2019-06-03T08:05:48Z Article Teoh, Phaik Ju, An, Omer, Chung, Tae-Hoon, Chooi, Jing Yuan, Toh, Sabrina HM, Fan, Shuangyi, Wang, Wilson, Koh, Bryan TH, Fullwood, Melissa J, Ooi, Melissa G, de Mel, Sanjay, Soekojo, Cinnie Y, Chen, Leilei, Ng, Siok Bian, Yang, Henry, Chng, Wee Joo (2018-09-20). Aberrant hyperediting of the myeloma transcriptome by ADAR1 confers oncogenicity and is a marker of poor prognosis. BLOOD 132 (12) : 1304-1317. ScholarBank@NUS Repository. https://doi.org/10.1182/blood-2018-02-832576 0006-4971 1528-0020 https://scholarbank.nus.edu.sg/handle/10635/155188 en AMER SOC HEMATOLOGY Elements
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
language	English
topic	Science & Technology Life Sciences & Biomedicine Hematology MULTIPLE-MYELOMA GENE AMPLIFICATION RNA ACTIVATION ABNORMALITIES INHIBITION
spellingShingle	Science & Technology Life Sciences & Biomedicine Hematology MULTIPLE-MYELOMA GENE AMPLIFICATION RNA ACTIVATION ABNORMALITIES INHIBITION Teoh, Phaik Ju An, Omer Chung, Tae-Hoon Chooi, Jing Yuan Toh, Sabrina HM Fan, Shuangyi Wang, Wilson Koh, Bryan TH Fullwood, Melissa J Ooi, Melissa G de Mel, Sanjay Soekojo, Cinnie Y Chen, Leilei Ng, Siok Bian Yang, Henry Chng, Wee Joo Aberrant hyperediting of the myeloma transcriptome by ADAR1 confers oncogenicity and is a marker of poor prognosis
description	10.1182/blood-2018-02-832576
author2	CANCER SCIENCE INSTITUTE OF SINGAPORE
author_facet	CANCER SCIENCE INSTITUTE OF SINGAPORE Teoh, Phaik Ju An, Omer Chung, Tae-Hoon Chooi, Jing Yuan Toh, Sabrina HM Fan, Shuangyi Wang, Wilson Koh, Bryan TH Fullwood, Melissa J Ooi, Melissa G de Mel, Sanjay Soekojo, Cinnie Y Chen, Leilei Ng, Siok Bian Yang, Henry Chng, Wee Joo
format	Article
author	Teoh, Phaik Ju An, Omer Chung, Tae-Hoon Chooi, Jing Yuan Toh, Sabrina HM Fan, Shuangyi Wang, Wilson Koh, Bryan TH Fullwood, Melissa J Ooi, Melissa G de Mel, Sanjay Soekojo, Cinnie Y Chen, Leilei Ng, Siok Bian Yang, Henry Chng, Wee Joo
author_sort	Teoh, Phaik Ju
title	Aberrant hyperediting of the myeloma transcriptome by ADAR1 confers oncogenicity and is a marker of poor prognosis
title_short	Aberrant hyperediting of the myeloma transcriptome by ADAR1 confers oncogenicity and is a marker of poor prognosis
title_full	Aberrant hyperediting of the myeloma transcriptome by ADAR1 confers oncogenicity and is a marker of poor prognosis
title_fullStr	Aberrant hyperediting of the myeloma transcriptome by ADAR1 confers oncogenicity and is a marker of poor prognosis
title_full_unstemmed	Aberrant hyperediting of the myeloma transcriptome by ADAR1 confers oncogenicity and is a marker of poor prognosis
title_sort	aberrant hyperediting of the myeloma transcriptome by adar1 confers oncogenicity and is a marker of poor prognosis
publisher	AMER SOC HEMATOLOGY
publishDate	2019
url	https://scholarbank.nus.edu.sg/handle/10635/155188
_version_	1800913616878174208

Aberrant hyperediting of the myeloma transcriptome by ADAR1 confers oncogenicity and is a marker of poor prognosis

Similar Items